Cover Image

Clinical significance of hormonal receptor status of malignant ovarian tumors

Saved in:

Bibliographic Details
Date:	2014
Main Authors:	I. G. Tkalia, L. I. Vorobyova, V. S. Svintsitsky, S. V. Nespryadko, I. V. Goncharuk, N. Y. Lukyanova, V. F. Chekhun
Format:	Article
Language:	English
Published:	2014
Series:	Experimental Oncology
Online Access:	http://jnas.nbuv.gov.ua/article/UJRN-0000294105
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Similar Items

Clinical significance of hormonal receptor status of malignant ovarian tumors
by: Tkalia, I.G., et al.
Published: (2014)

Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
by: I. G. Tkalia, et al.
Published: (2014)

Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
by: Tkalia, I.G., et al.
Published: (2014)

Recurrence of borderline ovarian tumors
by: V. S. Svintsitskiy, et al.
Published: (2013)

Recurrence of borderline ovarian tumors
by: Svintsitskiy, V.S., et al.
Published: (2013)

Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers
by: Buchynska, L.G., et al.
Published: (2009)

General clinical, biochemical parameters and peripheral blood hormone level in women at ovarian hyperstimulation syndrome
by: N. V. Avramenko, et al.
Published: (2018)

Chemocine receptor CXCR4 expression and microvessels density in malignant tumors of the breast of patients with sings of metabolic syndrome
by: N. P. Yurchenko, et al.
Published: (2020)

Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
by: Kryzhanivska, A.E., et al.
Published: (2018)

The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats
by: I. G. Tkalia, et al.
Published: (2015)

The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats
by: Tkalia, I.G., et al.
Published: (2015)

Clinical significance of estrogen receptor gene ERS1 SNP in cancer patients from families with oncological pathology in pedigrees
by: Paliychuk, O.V, et al.
Published: (2016)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: S. V. Chekhun, et al.
Published: (2014)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: Chekhun, S.V., et al.
Published: (2014)

Quantitative analysis of SLC34A2 expression in different types of ovarian tumors
by: Shyian, M., et al.
Published: (2011)

The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
by: V. F. Chekhun, et al.
Published: (2017)

Cytomegaloviruses and malignant brain tumors
by: Lisyany, N.I., et al.
Published: (2023)

Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: D. Y. Tsyhyka, et al.
Published: (2013)

Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: Tsyhyka, D.Y., et al.
Published: (2013)

Ovarian cancer: family cancer syndrome and clinical significance of testing of the mutations in BRCA1 and BRCA2?genes
by: O. V. Paliichuk, et al.
Published: (2016)

Expression of galectin-1 in malignant tumors
by: Demydenko, D., et al.
Published: (2009)

Expression of steroid and peptide hormone receptors, metabolic enzymes and EMT-related genes in prostate tumors in relation to the presence of the TMPRSS2/ERG fusion
by: Gerashchenko, G.V., et al.
Published: (2018)

Relationship between malignant tumor metabolism and tumor-bearing organism
by: T. N. Popovskaja, et al.
Published: (2019)

Hormonal impact on tumor growth and progression
by: A. Reznikov
Published: (2015)

Hormonal impact on tumor growth and progression
by: Reznikov, A.
Published: (2015)

Hormonal-sensitive breast cancer: molecular-biological and clinical aspects of preoperative antitumor hormone therapy
by: O. V. Ponomareva
Published: (2018)

Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
by: Chekhun, V.F., et al.
Published: (2009)

Clinical hormonal characteristics and therapy of girls with endometrial hyperplasia and anemia
by: I. A. Tuchkina, et al.
Published: (2014)

Vacuum cryo-thermal probe for destruction of malignant tumors
by: M. I. Gasanov, et al.
Published: (2013)

Protein and carbohydrate metabolism disorders in patients with malignant tumors of the intestine
by: T. N. Popovskaja, et al.
Published: (2018)

The peculiarities of ultra sound diagnostics of borderline ovarian tumors
by: E. S. Klimenko, et al.
Published: (2014)

The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: S. V. Vtorushin, et al.
Published: (2014)

The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: Vtorushin, S.V., et al.
Published: (2014)

Nanohyperthermia of malignant tumors. II. In vivo tumor heating with manganese perovskite nanoparticles
by: Bubnovskaya, L., et al.
Published: (2012)

Genetic and epigenetic changes in malignant cells of tumors of urogenital organs
by: Gordiyuk, V.V.
Published: (2010)

Clinical features of patients with syndrome of biologically inactive growth hormone
by: N. A. Sprynchuk
Published: (2019)

Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
by: Bereznaya, N.M., et al.
Published: (2008)

Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
by: O. D. Ryabtseva, et al.
Published: (2013)

Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
by: Ryabtseva, O.D., et al.
Published: (2013)

Anti-Muller hormone detection and Doppler study of ovary blood supply in diagnosis of poor ovarian response syndrome
by: V. A. Pitko, et al.
Published: (2013)